Cargando…
The Development of Cell-Penetrating Peptides for Efficient and Selective In Vivo Expression of mRNA in Spleen Tissue
mRNA-based therapeutics are presently one of the nucleic acid-based therapeutics with a high potential for extraordinary success as preventive vaccines. Current applications with mRNA therapeutics rely on lipid nanoparticle (LNP) mediated delivery of nucleic acids. In order to achieve the transition...
Autores principales: | Porosk, Ly, Härk, Heleri Heike, Arukuusk, Piret, Haljasorg, Uku, Peterson, Pärt, Kurrikoff, Kaido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055000/ https://www.ncbi.nlm.nih.gov/pubmed/36986813 http://dx.doi.org/10.3390/pharmaceutics15030952 |
Ejemplares similares
-
Modification of the Linker Amino Acid in the Cell-Penetrating Peptide NickFect55 Leads to Enhanced pDNA Transfection for In Vivo Applications
por: Härk, Heleri H., et al.
Publicado: (2023) -
Predicting Transiently Expressed Protein Yields: Comparison of Transfection Methods in CHO and HEK293
por: Porosk, Ly, et al.
Publicado: (2022) -
Cell-Penetrating Peptide and siRNA-Mediated Therapeutic Effects on Endometriosis and Cancer In Vitro Models
por: Kiisholts, Kristina, et al.
Publicado: (2021) -
Formulation of Stable and Homogeneous Cell-Penetrating Peptide NF55 Nanoparticles for Efficient Gene Delivery In Vivo
por: Freimann, Krista, et al.
Publicado: (2017) -
Aggregation Limiting Cell-Penetrating Peptides Derived from Protein Signal Sequences
por: Porosk, Ly, et al.
Publicado: (2023)